Personal information

Websites & social links

Linkedin
ResearchGate

Other IDs

Scopus Author ID: 14527816600

Countries

United States

Activities

Collapse all

Employment (6)

Roswell Park Comprehensive Cancer Center : Buffalo, New York, US

2022-05-05 to present | HRI Scientist (Department of Biostatistics and Bioinformatics)
Employment
Source: Self-asserted source
Henry G. Withers

Roswell Park Comprehensive Cancer Center: Buffalo, New York, US

2022-05-05 to present | Associate Director (Drug Discovery Core Shared Resource)
Employment
Source: Self-asserted source
Henry G. Withers

Roswell Park Comprehensive Cancer Center: Buffalo, NY, US

2021-05-06 to 2022-05-05 | Research Affiliate - Post-doctoral (Department of Biostatistics and Bioinformatics)
Employment
Source: Self-asserted source
Henry G. Withers

Veronomics Inc.: Buffalo, New York, US

2019-01 to 2021-05-05 | Director of Genomics
Employment
Source: Self-asserted source
Henry G. Withers

Roswell Park Cancer Institute: Buffalo, NY, US

2018-07 to 2018-12 | Research Affiliate - Postdoctoral (Department of Cancer Genetics and Genomics)
Employment
Source: Self-asserted source
Henry G. Withers

Roswell Park Cancer Institute: Buffalo, New York, US

2011-09 to 2018-06 | Pre-doctoral Candidate (Department of Cancer Genetics and Genomics)
Employment
Source: Self-asserted source
Henry G. Withers

Education and qualifications (4)

Roswell Park Cancer Institute: Buffalo, NY, US

2011-09-01 to 2018-06 | Ph.D. - Cancer Sciences (Cancer Genetics)
Education
Source: Self-asserted source
Henry G. Withers

University of Luxembourg: Luxembourg, LU

2009-09-01 to 2011-08-31 | M.S. Integrated Systems Biology
Education
Source: Self-asserted source
Henry G. Withers

Roswell Park Cancer Institute: Buffalo, NY, US

2009-09-01 to 2011-08-31 | Interdisciplinary M.S. - Natural and Biomedical Sciences (Cancer Genetics)
Education
Source: Self-asserted source
Henry G. Withers

Queen's University: Kingston, ON, CA

2003-09-01 to 2007-06-01 | Bachelor of Science, Honours - Biology
Education
Source: Self-asserted source
Henry G. Withers

Works (14)

STAG2 expression imparts distinct therapeutic vulnerabilities in muscle-invasive bladder cancer cells

Oncogenesis
2025-03-01 | Journal article
DOI: 10.1038/s41389-025-00548-3
Contributors: Sarah R. Athans; Henry Withers; Aimee Stablewski; Katerina Gurova; Joyce Ohm; Anna Woloszynska
Source: check_circle
Crossref

Multifactoral immune modulation potentiates durable remission in multiple models of aggressive malignancy

FASEB Journal
2024 | Journal article
DOI: 10.1096/fj.202302675R
EID:

2-s2.0-85192944472

Part of ISSN: 15306860 08926638
Contributors: Halpert, M.M.; Burns, B.A.; Rosario, S.R.; Withers, H.G.; Trivedi, A.J.; Hofferek, C.J.; Gephart, B.D.; Wang, H.; Vazquez-Perez, J.; Amanya, S.B. et al.
Source: Self-asserted source
Henry G. Withers via Scopus - Elsevier
grade
Preferred source (of 2)‎

NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs

Cancer Immunology Research
2024-10-01 | Journal article
DOI: 10.1158/2326-6066.CIR-24-0061
Contributors: Bowen Dong; Nataša Obermajer; Takemasa Tsuji; Junko Matsuzaki; Cindy M. Bonura; Cindy Sander; Henry Withers; Mark D. Long; Colin Chavel; Scott H. Olejniczak et al.
Source: check_circle
Crossref

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

Journal of Clinical Oncology
2023 | Journal article
DOI: 10.1200/JCO.22.00996
EID:

2-s2.0-85148964446

Part of ISSN: 15277755 0732183X
Contributors: Ahluwalia, M.S.; Reardon, D.A.; Abad, A.P.; Curry, W.T.; Wong, E.T.; Figel, S.A.; Mechtler, L.L.; Peereboom, D.M.; Hutson, A.D.; Withers, H.G. et al.
Source: Self-asserted source
Henry G. Withers via Scopus - Elsevier
grade
Preferred source (of 2)‎

MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells.

iScience
2023-10-11 | Journal article
DOI: 10.1016/j.isci.2023.108168
PMID: 37915591
PMC: PMC10616323
Contributors: Yamashita N; Withers H; Morimoto Y; Bhattacharya A; Haratake N; Daimon T; Fushimi A; Nakashoji A; Thorner AR; Isenhart E et al.
Source: Self-asserted source
Henry G. Withers
grade
Preferred source (of 2)‎

MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer

OncoImmunology
2022 | Journal article
DOI: 10.1080/2162402X.2022.2029298
EID:

2-s2.0-85124091678

Part of ISSN: 2162402X 21624011
Contributors: Hagiwara, M.; Fushimi, A.; Bhattacharya, A.; Yamashita, N.; Morimoto, Y.; Oya, M.; Withers, H.G.; Hu, Q.; Liu, T.; Liu, S. et al.
Source: Self-asserted source
Henry G. Withers via Scopus - Elsevier
grade
Preferred source (of 2)‎

MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance and Immunosuppression in Triple-Negative Breast Cancer

Molecular Cancer Research
2022-11-29 | Journal article | Author
DOI: 10.1158/1541-7786.mcr-22-0772
Part of ISSN: 1541-7786
Part of ISSN: 1557-3125
Contributors: Nami Yamashita; Yoshihiro Morimoto; Atsushi Fushimi; Rehan Ahmad; atrayee bhattacharya; Tatsuaki Daimon; Naoki Haratake; yuka; Satoshi Ishikawa; Masaaki Yamamoto et al.
Source: Self-asserted source
Henry G. Withers
grade
Preferred source (of 2)‎

Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non–neuroendocrine Small Cell Lung Cancer

Molecular Cancer Research
2022-06-16 | Journal article
DOI: 10.1158/1541-7786.mcr-22-0165
Part of ISSN: 1541-7786
Part of ISSN: 1557-3125
Source: Self-asserted source
Henry G. Withers
grade
Preferred source (of 2)‎

Identification of genes regulating breast cancer dormancy in 3D bone endosteal niche cultures

Molecular Cancer Research
2019 | Journal article
DOI: 10.1158/1541-7786.MCR-18-0956
EID:

2-s2.0-85062948180

Part of ISSN: 15573125 15417786
Contributors: McGrath, J.; Panzica, L.; Ransom, R.; Withers, H.G.; Gelman, I.H.
Source: Self-asserted source
Henry G. Withers via Scopus - Elsevier
grade
Preferred source (of 2)‎

Abstract LB-148: Characterization of an off-target RNAi genomic screen hit identifies GPRC6A as a novel suppressor of metastatic chemotaxis and invasiveness

Cancer Research
2017 | Journal article
DOI: 10.1158/1538-7445.AM2017-LB-148
ARXIV:

http://cancerres.aacrjournals.org/content
Source: Self-asserted source
Henry G. Withers

VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer

Scientific Reports
2017 | Journal article
DOI: 10.1038/s41598-017-06227-7
EID:

2-s2.0-85025821990

Part of ISSN: 20452322
Contributors: Zhang, Y.; Shen, H.; Withers, H.G.; Yang, N.; Denson, K.E.; Mussell, A.L.; Truskinovsky, A.; Fan, Q.; Gelman, I.H.; Frangou, C. et al.
Source: Self-asserted source
Henry G. Withers via Scopus - Elsevier
grade
Preferred source (of 2)‎

Abstract LB-167: Off-target analysis of RNAi screens identifies microRNA seed sequence contributing to metastatic invasion

Cancer Research
2016 | Journal article
DOI: 10.1158/1538-7445.AM2016-LB-167
ARXIV:

http://cancerres.aacrjournals.org/content/76/14_Supplement/LB-167
Source: Self-asserted source
Henry G. Withers

Hypoxia and the metabolic phenotype of prostate cancer cells

Biochimica et Biophysica Acta (BBA) - Bioenergetics
2009 | Journal article
DOI: https://doi.org/10.1016/j.bbabio.2009.06.003
Source: Self-asserted source
Henry G. Withers
grade
Preferred source (of 2)‎

Inhibition of Cellular Respiration by Doxorubicin

Chemical Research in Toxicology
2006 | Journal article
DOI: 10.1021/tx050315y
ARXIV:

http://dx.doi.org/10.1021/tx050315y

Source: Self-asserted source
Henry G. Withers
grade
Preferred source (of 2)‎
How many people are using ORCID?